---
title: "Camp4 net loss widens to $33.5 million in Q2 FY26"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295842670.md"
description: "Camp4 Therapeutics reported a widened net loss of $33.5 million for Q2 FY26, up from $12.6 million previously. The increase was driven by a $20.9 million non-cash fair-value loss on derivative liabilities. Operating expenses saw slight rises in R&D and G&A. Cash reserves decreased to $86.4 million, though the company added $50.1 million post-quarter. Regulatory approvals in Australia and Argentina support an upcoming Phase 1/2 trial for SYNGAP1."
datetime: "2026-08-13T20:31:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295842670.md)
  - [en](https://longbridge.com/en/news/295842670.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295842670.md)
generator: "portal-rs"
---

# Camp4 net loss widens to $33.5 million in Q2 FY26

-   Camp4 posted a net loss of USD 33.5 million for Q2 2026, widening from USD 12.6 million a year earlier. \* R&D expense rose to USD 10.8 million from USD 10.3 million; G&A edged up to USD 4.3 million from USD 4.2 million. \* The loss widened due to a USD 20.9 million non-cash fair-value loss tied to a derivative tranche liability from its September 2025 private placement. \* Cash and cash equivalents fell to USD 86.4 million at June 30 from USD 109.5 million at Dec. 31; added USD 50.1 million post-quarter. \* Regulatory clearance in Australia and Argentina supports a first-in-human Phase 1⁄2 CMP-002 trial in SYNGAP1, with launch expected in Q4 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Camp4 Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-056758), on August 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CAMP.US](https://longbridge.com/en/quote/CAMP.US.md)

## Related News & Research

- [Quanta Services announces dividend of R$ 0.03 per unit for Q3 2026](https://longbridge.com/en/news/297931955.md)
- [Pininfarina announces availability of H1 2026 interim financial report](https://longbridge.com/en/news/298044460.md)
- [Alexandria Real Estate Equities declares Q3 2026 dividend of R$ 0.63 per unit](https://longbridge.com/en/news/297928934.md)
- [Marisa updates financial events calendar for 2026](https://longbridge.com/en/news/297913424.md)
- [Americold Realty Trust declares Q3 2026 dividend of R$ 0.27 per unit](https://longbridge.com/en/news/297823075.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**